Charles H. Sherwood, CEO and Director at Anika Therapeutics, Inc. (ANIK), sold 56,438 shares at $60.04 ($3.4M) on 2017-10-20, disclosed to the SEC on 2017-10-24.
Open-market sale of $3.4M ANIK by CEO and Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $60.04 | 5,991 | $360K | 10.6% |
| 2 | $60.04 | 5,991 | $360K | 10.6% |
| 3 | $60.06 | 22,228 | $1.3M | 39.4% |
| 4 | $60.06 | 22,228 | $1.3M | 39.4% |
| Total | $60.06 avg | 56,438 | $3.4M | 100% |
| Filing → |
| ANIK | SELL | 2017-10-16 | $742K | — | Filing → |
| ANIK | SELL | 2017-07-31 | $6.5M | — | Filing → |
| ANIK | SELL | 2017-07-06 | $1.1M | — | Filing → |